As a leading innovator of Cannabis research, product development and technology, Cronos Group is fast creating an iconic brand portfolio comprising of cannabis-based products catering to both recreational and medicinal use.
Do you want to invest on Cronos? we'll tell you how.
Industry: Drug Manufacturers
After Altria—makers of Marlboro cigarettes—invested more than $1.8 billion in 2018, Cronos is seen as a more formidable player in the emerging cannabis industry, translating to increased sales and revenues in the last few years.
And there’s more…
Just this year alone, Cronos has launched a Hemp-based CBD brand called "Happy Dance", which proved to be a hit in the US Market. The company also got an approval to start marketing the PEACE NATURALS cannabis oil in Israel.
Bear in mind…
In this article, we will discuss the idea of investing on Cronos stocks by mulling over its stock performance history and analyst forecast of future share value.
If you’re ready, then let’s start learning about the promising idea of investing on Cronos stocks
Table of Contents
- Why Buy Cronos Stock?
- Cronos Stock Performance
- Cronos Stock Forecast
- How to Buy Cronos Stock?
- Frequently Asked Questions (FAQ)
- Best Brokers for Buying Cronos Stocks
Why Buy Cronos Stock?
There is a growing optimism in the continued surge of the Cannabis industry as more places such as New Jersey, South Dakota and Arizona in the United States have voted for the legalization of recreational use of cannabis.
All these positive developments plus the fact that US President-elect Joe Biden has also promised for the decriminalization of cannabis use at the federal level.
These relaxing of restrictions in the consumption of marijuana will greatly benefit and help shape Cronos' revenue growth in the coming years ahead.
Cronos Stock Performance
After a string of strong performance on the market, investors now see Cronos shares as a "sizzling prospect" especially if one factor in the long-term approach of the company and the consistent revenue growth as the cannabis industry continues to become popular all over the world.
With shares outstanding rising to $356 million, the company's market cap has also soared to $2.54 billion.
- Copy investment portfolios of top Cronos traders
- Buy stocks commission-free
- Practice with a free demo account
- No overnight fees
- Risk management tools
Taking the online trading industry by storm, eToro has now garnered more than 13 million users since it was founded in 2006.
This highly-trusted e-trading application is the ideal investing tool for both seasoned and beginner traders.
Want to know how to use eToro? We will tell you how
- Sign up for an account by creating one at the sign-in page.
- Verify your personal information for security purposes.
- Make your first deposit.
- And as easy as 1,2,3, you can now start trading.
eToro’s fantastic set of features include:
CopyTrading - this is a robust feature that provides users a medium to search and copy successful traders for them to learn and invest properly.
CopyPortfolios - this is another valuable feature that teaches traders the proper way of expanding their portfolios without risking their investments by reducing the chances of experiencing losses through wise trading decisions.
And another thing:
The Analyst Coverage page is where users can find beneficial information about the industry, the market, company stocks, forecasts and other data you can use when making investment decisions.
eToro is also licensed by different regulatory bodies including the following:
- CySEC – Cyprus Securities and Exchange Commission
- FCA – Financial Conduct Authority
- ASIC – Australian Securities and Investments Commission
- Competitive spreads for Cronos
- Trading with as little as $100
- Fast and reliable order execution
- Risk management tools
- Fully regulated by the FCA, CySEC and ASIC
The trademarked online trading platform of Plus500 is one of the most popular and highly-trusted tools used by investors for investing, trading and managing portfolios.
Trading made easier by Plus500
Plus500’s Integrated Risk Management Tools help users avoid investment risks by giving traders integrated control of their investment.
One more thing…
Plus500 online trading platform follows all rules and guidelines set by financial governing bodies and is regulated by leading regulatory boards:
- Plus500CY Ltd authorized & regulated by CySEC (#250/14).
- Plus500UK Ltd authorised & regulated by the FCA (#509909).
- Plus500SG Pte Ltd, licensed by the MAS (#CMS100648-1) and IE Singapore (#PLUS/CBL/2018).
- Plus500AU Pty Ltd (ACN 153301681), licensed by:
ASIC in Australia, AFSL #417727, FMA in New Zealand, FSP #486026; Authorised Financial Services Provider in South Africa, FSP #47546. You do not own or have any rights to the underlying assets. Please refer to the Disclosure documents available on the website.
Cronos Stock Forecast
Below is a summary of Cronos future and its relation to the potential value of its stocks.
These stock forecasts are based on current stock and company performance and is meant to guide your decision-making.
Remember, that the final decision is still yours to make.
2021: Leading the Anticipated Growth of the Cannabis Industry
As stated by Cronos CEO Kurt Schmidt "Revenue growth year over year was driven primarily by the continued growth in the adult use Canadian cannabis market and the sale of PEACE NATURALS branded cannabis products to the Israeli medical market", consumers interest in the cannabis industry is increasing and Cronos is among the top Cannabis companies expected to lead this industry movement in the coming years as more countries and cities around the world starts to allow or relax its policies against the use of cannabis for medical and even recreational use.
Our outlook for Cronos stock remains consistently high so we expect its share value to return high-yield range from medium to high.
2022: Expanding the Untapped Potential of the CBD Market
As evidenced by the 2019 Oscar Awards' gift bags composed of CBD products, the CBD market is now seen as a vast untapped market teeming with promising revenue returns. Cronos is positioning itself to become one of the leading players to take advantage of this emerging market segment, by rolling off several additional CBD products in the future to further boost its revenue.
Our positive forecast remains the same and it will be for the next several years. Therefore, the chances of getting high on Cronos’ stock ranges from medium to high.
How to Buy Cronos Stock?
Simply follow the steps below and you're good to go:
Open an account with an online broker.
For you to buy Cronos stock and other company shares, first you need to open an account with a brokerage which offers a platform for trading.
Signing-up for an account only takes a few minutes to accomplish and after completing this process, you need to make a deposit so you can start investing.
Open your broker's trading platform.
Let's say you have opened an account with a specific brokerage and you have already funded it. The next step to do is to open their platform to start trading.
Look for the Cronos stock (symbol: CRON).
After opening the platform, search for the Cronos stock by using the search bar and entering either "Cronos" or its stock symbol "CRON".
Select Buy and set the amount.
Click on "Buy" and specify the amount that you wish to invest. You may also set several specific parameters depending the features that are offered to you by your broker.
Execute the order.
Initiate the trade by executing the order.
Should I buy Cronos stock?
Following the announcement of Cronos' third-quarter results for 2020, which revealed a strong revenue increase shattering analyst's estimates, Cronos is seen as a promising stock leading the expected growth of the cannabis industry. By having built and expanded its business through strategic acquisitions and partnerships, Cronos is forecasted to see solid yields in the coming years. This also means, a BUY rating for its stocks.
So, are you are ready to trade Cronos shares?
If you are now sold on buying and trading Cronos stocks, then we highly encourage you to look for a highly trusted and regulated brokerage firm that can promise you appropriate management and control of your investments.
Frequently Asked Questions (FAQ)
How Much is the Cronos Stock?
Here is the current stock market price of ( )
Who Owns the Most Shares of Cronos?
The Chescapmanager LLC owns the largest number of Cronos shares with 8,873,890 stocks valued at $44,458,188.
How Many Outstanding Shares Does Cronos Have?
Based on latest figures, Cronos’ outstanding shares is 356.19 million
Where Can I Buy Cronos Stock?
When buying Cronos stocks, we highly recommend the two leading online trading platforms used by many traders today. These are the Plus500 and eToro, two popular CFD (contracts for difference) trading applications trusted by investors all over the world.
Best Brokers for Buying Cronos Stocks
We've prepared a table of the most trusted and regulated brokers that offers Cronos stock CFD trading services.
All you have to do is click on the Cronos Page button of your preferred broker and you will be taken straight to their stock trading page.
Min Deposit: $200
Regulation: CYSEC, FCA
Min Deposit: $100
Regulation: FCA, ASIC, CySEC
Min Deposit: $5
Regulation: IFSC, ASIC, CySEC